Latest News and Press Releases

Marvel Biosciences secures $600,000 in non-dilutive funding from Alberta Innovates to support Phase I clinical trials of its autism-focused patented MB-204

Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204, lead asset discovery, a patented neuroactive adenosine A2A antagonist

Nasdaq Private Market receives U.S. patent for settlement engine for private company securities, a first for the private market industry

Biotech and healthcare innovators are advancing novel therapies and strategic platforms amid rising demand for targeted treatments and efficient global ac

Approval in Costa Rica for Kinesiology Tape Products

CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent

CDT Positions for Transformational Growth

David Ebrahimzadeh launches Patent Portal, an AI-powered platform for inventors, built from his experience securing multiple U.S. automotive safety patents

NorthStrive Biosciences Files 10 U.S. Patent Applications for EL-22 and EL-32 Targeting Muscle Growth and Yield Enhancement in Farmed Animals

Distribution agreement